Treatment of Refractory Opioid Use Disorder

J Gen Intern Med. 2021 Jun;36(6):1792. doi: 10.1007/s11606-021-06718-4. Epub 2021 Apr 7.

Authors

Mimi Yen Li¹, Julian A Mitton², Benjamin I Bearnot^{3

4}

Affiliations

¹ Harvard Medical School, Boston, MA, USA. Mimi_yenli@hms.harvard.edu.
² Enterprise Population Health, CommonSpirit Health, San Francisco, CA, USA.
³ Harvard Medical School, Boston, MA, USA.
⁴ Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Analgesics, Opioid / therapeutic use
Canada
Humans
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / epidemiology
United States

Substances

Analgesics, Opioid

Grants and funding